SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Equity Investment Life Holding Co. – ‘10-Q’ for 3/31/22 – ‘EX-10.2’

On:  Monday, 5/9/22, at 5:18pm ET   ·   For:  3/31/22   ·   Accession #:  1039828-22-42   ·   File #:  1-31911

Previous ‘10-Q’:  ‘10-Q’ on 11/9/21 for 9/30/21   ·   Next:  ‘10-Q’ on 8/9/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 5/10/24 for 3/31/24   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/09/22  American Equity Inv Life Hold… Co 10-Q        3/31/22   77:14M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.64M 
 2: EX-10.1     Material Contract                                   HTML     45K 
 3: EX-10.2     Material Contract                                   HTML     44K 
 4: EX-10.3     Material Contract                                   HTML     41K 
 5: EX-10.4     Material Contract                                   HTML     26K 
 6: EX-10.5     Material Contract                                   HTML     75K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
16: R1          Cover Page                                          HTML     83K 
17: R2          Consolidated Balance Sheets                         HTML    144K 
18: R3          Consolidated Balance Sheets (Parentheticals)        HTML     78K 
19: R4          Consolidated Statements of Operations               HTML    132K 
20: R5          Consolidated Statements of Comprehensive Loss       HTML     59K 
21: R6          Consolidated Statements of Changes in               HTML     73K 
                Stockholders' Equity                                             
22: R7          Consolidated Statements of Cash Flows               HTML    159K 
23: R8          Significant Accounting Policies                     HTML     30K 
24: R9          Fair Values of Financial Instruments                HTML    187K 
25: R10         Investments                                         HTML    266K 
26: R11         Mortgage Loans on Real Estate                       HTML    417K 
27: R12         Variable Interest Entities                          HTML     46K 
28: R13         Derivative Instruments                              HTML     92K 
29: R14         Notes Payable                                       HTML     36K 
30: R15         Commitments and Contingencies                       HTML     28K 
31: R16         Earnings Per Common Share and Stockholders' Equity  HTML     46K 
32: R17         Significant Accounting Policies (Policies)          HTML     75K 
33: R18         Fair Values of Financial Instruments (Tables)       HTML    193K 
34: R19         Investments (Tables)                                HTML    265K 
35: R20         Mortgage Loans on Real Estate (Tables)              HTML    411K 
36: R21         Variable Interest Entities (Tables)                 HTML     45K 
37: R22         Derivative Instruments (Tables)                     HTML     93K 
38: R23         Notes Payable (Tables)                              HTML     35K 
39: R24         Earnings Per Common Share and Stockholders' Equity  HTML     38K 
                (Tables)                                                         
40: R25         Fair Values of Financial Instruments (Narrative)    HTML     63K 
                (Details)                                                        
41: R26         Fair Values of Financial Instruments (Fair Values   HTML     65K 
                and Carrying Amounts of Financial Instruments)                   
                (Details)                                                        
42: R27         Fair Values of Financial Instruments (Assets and    HTML    114K 
                Liabilities Measured on a Recurring Basis by Fair                
                Value Hierarchy) (Details)                                       
43: R28         Fair Values of Financial Instruments (Assumptions   HTML     59K 
                Used in Estimating Fair Value) (Details)                         
44: R29         Fair Values of Financial Instruments                HTML     59K 
                (Reconciliation of Beginning and Ending Balances                 
                of Level 3 Assets and Liabilities) (Details)                     
45: R30         Investments (Narrative) (Details)                   HTML     35K 
46: R31         Investments (Schedule of Fixed Maturity             HTML     79K 
                Securities) (Details)                                            
47: R32         Investments (Fixed Maturity Securities by           HTML     75K 
                Contractual Maturity) (Details)                                  
48: R33         Investments (Net Unrealized Gains on Available for  HTML     36K 
                Sale Fixed Maturity Securities Reported as a                     
                Separate Component of Stockholders' Equity)                      
                (Details)                                                        
49: R34         Investments (Credit Quality of Fixed Maturity       HTML     44K 
                Security Portfolio by NAIC Designation) (Details)                
50: R35         Investments (Gross Unrealized Losses on             HTML     95K 
                Investments, By Category and Length of Time)                     
                (Details)                                                        
51: R36         Investments (Changes in Net Unrealized              HTML     37K 
                Gains/Losses on Investments) (Details)                           
52: R37         Investments (Net Realized Gains (Losses) on         HTML     44K 
                Invesments) (Details)                                            
53: R38         Investments (Rollforward of Allowance for Credit    HTML     53K 
                Loss) (Details)                                                  
54: R39         Mortgage Loans on Real Estate (Narrative)           HTML     50K 
                (Details)                                                        
55: R40         Mortgage Loans on Real Estate (Summary of Mortgage  HTML     51K 
                Loan Portfolio) (Details)                                        
56: R41         Mortgage Loans on Real Estate (Commercial Mortgage  HTML     75K 
                Loan Portfolio Summarized by Geographic Region and               
                Property Type) (Details)                                         
57: R42         Mortgage Loans on Real Estate (Rollforward of       HTML     46K 
                Valuation Allowance on Mortgage Loan Portfolios)                 
                (Details)                                                        
58: R43         Mortgage Loans on Real Estate (Summary By Debt      HTML    130K 
                Service Coverage and Loan to Value Ratios)                       
                (Details)                                                        
59: R44         Mortgage Loans on Real Estate (Aging of Financing   HTML     99K 
                Receivables) (Details)                                           
60: R45         Variable Interest Entities (Consolidated VIEs)      HTML     54K 
                (Details)                                                        
61: R46         Variable Interest Entities (Unconsolidated VIEs)    HTML     39K 
                (Details)                                                        
62: R47         Derivative Instruments (Narrative) (Details)        HTML     33K 
63: R48         Derivative Instruments (Fair Value of Derivative    HTML     39K 
                Instruments as Presented in the Consolidated                     
                Balance Sheets) (Details)                                        
64: R49         Derivative Instruments (Change in Fair Value of     HTML     39K 
                Derivatives Included in the Consolidated Statement               
                of Operations) (Details)                                         
65: R50         Derivative Instruments (Derivative Call Options,    HTML     59K 
                Notional Amount and Fair Value, by Counterparty)                 
                (Details)                                                        
66: R51         Notes Payable (Schedule of Notes Payable)           HTML     36K 
                (Details)                                                        
67: R52         Notes Payable (2027 Notes Narrative) (Details)      HTML     34K 
68: R53         Commitments and Contingencies (Narrative)           HTML     33K 
                (Details)                                                        
69: R54         Earnings Per Common Share and Stockholders' Equity  HTML     60K 
                (Schedule of Earnings Per Common Share, Basic and                
                Diluted) (Details)                                               
70: R55         Earnings Per Common Share and Stockholders' Equity  HTML     46K 
                (Stockholders' Equity) (Details)                                 
71: R56         Earnings Per Common Share and Stockholders' Equity  HTML     37K 
                (Brookfield) (Details)                                           
72: R57         Earnings Per Common Share and Stockholders' Equity  HTML     40K 
                (Share Repurchase Program and Treasury Stock)                    
                (Details)                                                        
75: XML         IDEA XML File -- Filing Summary                      XML    138K 
73: XML         XBRL Instance -- ael-20220331_htm                    XML   4.61M 
74: EXCEL       IDEA Workbook of Financial Reports                  XLSX    117K 
12: EX-101.CAL  XBRL Calculations -- ael-20220331_cal                XML    229K 
13: EX-101.DEF  XBRL Definitions -- ael-20220331_def                 XML   1.00M 
14: EX-101.LAB  XBRL Labels -- ael-20220331_lab                      XML   1.83M 
15: EX-101.PRE  XBRL Presentations -- ael-20220331_pre               XML   1.15M 
11: EX-101.SCH  XBRL Schema -- ael-20220331                          XSD    164K 
76: JSON        XBRL Instance as JSON Data -- MetaLinks              439±   672K 
77: ZIP         XBRL Zipped Folder -- 0001039828-22-000042-xbrl      Zip    449K 


‘EX-10.2’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 10.2

2022 TIME BASED AWARD
EMPLOYEE RESTRICTED STOCK UNIT
AWARD AGREEMENT
This Employee Restricted Stock Unit Award Agreement (this “Agreement”), dated as of [[GRANTDATE]] (the “Date of Grant”), is made by and between the Company, and [[FIRSTNAME]] [[LASTNAME]] (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the American Equity Investment Life Holding Company Amended and Restated Equity Incentive Plan (the “Plan”). Except where the context indicates otherwise, references to the Company shall include any successor to the Company.
WHEREAS, the Company and certain Affiliates have adopted the Plan under which participants may receive Company restricted stock units that are subject to time-based vesting conditions;
WHEREAS, the Compensation and Talent Management Committee of the Board of Directors of the Company (the “Committee”) recommended restricted stock units (“RSUs”) for the Participant under the Plan and the Board of Directors of the Company approved such RSUs, and pursuant to the terms of the award, the Participant shall receive the number of RSUs provided for herein;
NOW, THEREFORE, in consideration for the promises and the covenants of the parties contained in this Agreement, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto, for themselves, their successors and assigns, hereby agree as follows:
1.Grant of Restricted Stock Unit Award; Change in Control. The Company hereby grants to the Participant [[SHARESGRANTED]] RSUs (such number, the “Number” of RSUs) on the terms and conditions set forth in this Agreement and as otherwise provided in the Plan (the “Award”). Notwithstanding any other provisions in this Agreement to the contrary, in the event of a Change in Control, the RSUs shall be treated in accordance with Section 10.1 and Section 10.2 of the Plan.
2.Restrictions. The RSUs may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of or encumbered and shall be subject to a risk of forfeiture as described in Section 3 hereof until such restrictions have lapsed in accordance with Section 3 hereof. Upon any attempt by the Participant to transfer any of the RSUs or any rights in respect of the RSUs before the lapse of such restrictions, such RSUs and all of the rights related thereto, shall be immediately forfeited by the Participant without payment of any consideration. The restrictions applicable to the RSUs shall lapse only in accordance with Section 3 hereof.
3.Vesting/Forfeiture
a.General. Subject to Sections 3(b) - (e) hereof, the restrictions applicable to the RSUs, as described in Section 2 hereof, shall lapse with respect to one-hundred percent (100%) of the RSUs on the [third (3d) /second (2d)] anniversary of the Date of Grant. The period from Date of Grant until the date the restrictions lapse in accordance with this Section 3(a) is the “Restriction Period.”
b.Participant Violation of Terms; Termination For Cause or Detrimental Activity. If, during the Restriction Period, as determined at any time in the discretion of the Company or an Affiliate, the Participant violated any of the Participant’s obligations under this Agreement, including those provided by Section 9 hereof, or the Participant violated any of the Participant’s obligations under any separation agreement, or Participant’s actions qualify or qualified for a Termination For Cause or Detrimental Activity (each as defined in the Plan), then no RSUs will be due the Participant from the Company.
c.Death/Disability/Retirement During Restriction Period. Subject to Section 3(b) hereof, in the event of a Termination during the Restriction Period due to the Participant’s death or Disability, or due to the Participant’s Retirement, the restrictions applicable to the RSUs, as described in Section 2 hereof, shall lapse with respect to one-hundred percent (100%) of the RSUs.
d.Termination During Restriction Period With Final Separation Agreement.
i.Subject to Section 3(b) hereof, in the event of (A) a Termination during the Restriction Period and prior to an event described in Section 3(c) hereof, (B) the Participant is offered a separation agreement, (C) such separation agreement has become final and effective, and (D) the Company’s Chief Executive Officer or Chief Human Resources Officer (or, in the case of a Participant who is an executive officer of the Company as provided in the charter of the Committee, the Committee or Board of Directors) determines as a matter of discretion to apply this Section 3(d), the RSUs shall immediately be forfeited and the Company or an Affiliate will make a Prorata RSU Cash Payment (as defined herein) to the Participant as soon as practicable after (and in no case more than seventy-four days after) the end of the Restriction Period (the “Payment Date”); provided, however, that if, during the Restriction Period, the Participant has violated, as determined at any time in the discretion of the Company, any of the Participant’s obligations under the separation agreement, no payment will be due the Participant from the Company. The Participant understands that he or she (and not the Company or any Affiliate) shall be responsible for any tax liability that may arise with respect to any such payment, and that the Company or an Affiliate shall withhold from such payment for taxes and any other required items.
ii.The Prorata RSU Cash Payment will be equal to:
A.the Number of RSUs; times
B.the lesser of the closing price of a Share on the Date of Grant or the last day of the Restriction Period; times



2022 TIME-BASED AWARD
C.the number of anniversaries of the beginning of the Restriction Period that passed as of the day following Termination divided by the total number of such anniversaries to and including the anniversary at the end of the Restriction Period.
e.Other Termination During Restriction Period. If, during the Restriction Period and prior to an event described in Section 3(b) - (d) hereof, Termination occurs for any reason, the RSUs shall immediately be forfeited without consideration.
4.Shareholder Rights. The RSUs are bookkeeping entries only. The Participant shall not have any privileges of a shareholder of the Company with respect to the RSUs awarded hereunder, including without limitation any right to vote shares of Common Stock underlying the RSUs or to receive dividends or other distributions in respect thereof (provided that any dividends or dividend equivalents on the RSUs shall only become payable on the same date on which the RSU from which the dividend equivalent right is derived is paid, subject to the terms hereof). All such dividend equivalent rights shall be subject to the same vesting requirements that apply to RSUs from which the dividend equivalent rights are derived.
5.Legend on Certificates. Certificates evidencing the RSUs awarded to the Participant hereunder shall bear such legends as the Company may determine in its sole discretion.
6.Securities Laws Requirements. The Company shall not be obligated to issue Common Stock to the Participant free of any restrictive legend described in Section 5 hereof or of any other restrictive legend, if such transfer, in the opinion of counsel for the Company, would violate the Securities Act of 1933, as amended (the “Securities Act”) (or any other federal or state statutes having similar requirements as may be in effect at that time).
7.No Obligation to Register. The Company shall be under no obligation to register the RSUs pursuant to the Securities Act or any other federal or state securities laws.
8.[reserved].
9.Non-Solicitation of Employees and Others. Participant agrees that from the Date of Grant until the completion of all payments (whether Shares or Cash) pursuant to this Agreement, Participant will not solicit any employee, customer, vendor, consultant, Independent Marketing Organization (or individual affiliate with any such organizations) of the Company or any Affiliate to end, reduce the time or scope of, decline to renew, or decline to extend the sales or other business volume, time, or scope of such relationship. Participant also agrees that from the Date of Grant until the end of twelve (12) months following Termination, Participant will not, without the prior written consent of the Company, and to the extent such consent is limited or conditioned, be employed by, engaged by, or otherwise assist, either as an individual or as a partner, joint venturer, employee, agent, consultant, officer, trustee, director, owner, part-owner, shareholder (except for less than 1% ownership of the common stock of a publicly-traded company), or in any other capacity, directly or indirectly, providing the same or similar activities, skills, experience, or expertise Participant performed for the Company and its Affiliates to any entities that the Company identifies as a competitor in its Compensation Discussion and Analysis publicly disclosed to the U.S. Securities and Exchange Commission within twelve (12) months on or prior to Termination. These prohibitions shall apply to each entity and its parents, subsidiaries, affiliates, or agents, or any entity with 9.9% or greater direct or indirect economic interest in any of them.
10.Timing and Manner of Payment of RSUs.
a.Subject to Section 3 hereof, and except as otherwise provided in this Section 10 hereof, as soon as practicable after (and in no case more than seventy-four days after) the end of the Restriction Period (the “Payment Date”), such RSUs whose restrictions have lapsed shall be paid by the Company delivering to the Participant a number of Shares equal to the number of RSUs that are non-forfeitable on that Payment Date (rounded down to the nearest whole share). The Company shall issue the Shares either (i) in certificate form or (ii) in book entry form, registered in the name of the Participant. Delivery of any certificates will be made to the Participant’s last address reflected on the books of the Company and its Affiliates unless the Company is otherwise instructed in writing. The Participant shall not be required to pay any cash consideration for the RSUs or for any Shares received pursuant to the Award. Neither the Participant nor any of the Participant’s successors, heirs, assigns or personal representatives shall have any further rights or interests in any RSUs that are so paid. Notwithstanding anything herein to the contrary, the Company shall have no obligation to issue Shares in payment of the RSUs unless such issuance and such payment shall comply with all relevant provisions of law and the requirements of any stock exchange on which the Shares are listed.
b.If, after the Restriction Period, as determined at any time in the discretion of the Company or an Affiliate, the Participant violated any of the Participant’s obligations under this Agreement, including those provided by Section 9 hereof, or the Participant violated any of the Participant’s obligations under any separation agreement, or Participant’s actions qualify or qualified for a Termination For Cause or Detrimental Activity (each as defined in the Plan), then no RSUs will be due the Participant from the Company.
11.Payments to “Specified Employees” Under Certain Circumstances. Notwithstanding the provisions of Section 3 and Section 4 hereof, if the Grantee is deemed a “specified employee” (as such term is described in Section 409A of the Code and the treasury regulations thereunder (the “Code”)) at a time when such Grantee becomes eligible for payment upon a “separation from service” with the Company or any of its Affiliates, to the extent required to avoid taxation under Section 409A of the Code, such payments shall be made to the Grantee on the date that is six (6) months following such “separation from service,” or upon the Grantee’s death, if earlier.
2



2022 TIME-BASED AWARD
12.Taxes. The Participant understands that he or she (and not the Company or any Affiliate) shall be responsible for any tax liability that may arise with respect to the RSUs granted under this Agreement. The Participant shall pay to the Company, or make provision satisfactory to the Company for payment of, any taxes or social insurance contributions required by law to be withheld with respect to the RSUs no later than the date of the event creating such tax liability. The Participant may satisfy the foregoing requirement by making a payment to the Company in cash or, in the Committee’s discretion, such amount may be paid in whole or in part by electing to have the Company retain the Participant’s Shares, with the retained Shares having a value equal to the amount of tax to be so withheld. Such Shares shall be valued at their Fair Market Value on the date of retention or delivery. If a Participant makes an election under Section 83(b) of the Code to be taxed with respect to the RSUs as of the date of transfer of the RSUs rather than as of the date or dates upon which the Participant would otherwise be taxable under Section 83(a) of the Code, the Participant shall be required to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue Service.
13.Failure to Enforce Not a Waiver. The failure of the Company or an Affiliate to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.
14.Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Iowa.
15.Incorporation of Plan. The Plan is hereby incorporated by reference and made a part hereof, and the RSUs and this Agreement shall be subject to all terms and conditions of the Plan and this Agreement.
16.Agreement Binding on Successors. The terms of this Agreement shall be binding upon the Participant and upon the Participant’s heirs, executors, administrators, personal representatives, transferees, assignees and successors in interest, and upon the Company and its successors and assignees.
17.No Assignment. Notwithstanding anything to the contrary in this Agreement, neither this Agreement nor any rights granted herein shall be assignable by the Participant.
18.Necessary Acts. The Participant hereby agrees to perform all acts, and to execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Agreement, including but not limited to all acts and documents related to compliance with federal and/or state securities and/or tax laws.
19.Entire Agreement. This Agreement contains the entire agreement and understanding among the parties as to the subject matter hereof.
20.Headings. Headings are used solely for the convenience of the parties and shall not be deemed to be a limitation upon or descriptive of the contents of any such section hereof.
21.Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.
22.Amendment. The Committee may amend the terms of this Agreement prospectively or retroactively at any time, but no such amendment shall impair the rights of the Participant hereunder without his or her consent.
[Remainder of page intentionally left blank.]

3



2022 TIME-BASED AWARD
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first set forth above.

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

By: /s/ [name]
[name]
[title]

PARTICIPANT
[[FIRSTNAME]] [[LASTNAME]]
[[SIGNATURE]]
[[SIGNATURE_DATE]]


4


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/9/22None on these Dates
For Period end:3/31/22
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/24  American Equity Inv Life Hold… Co 10-K/A     12/31/23   14:934K
 2/29/24  American Equity Inv Life Hold… Co 10-K       12/31/23  155:26M
 2/28/23  American Equity Inv Life Hold… Co 10-K       12/31/22  134:24M
11/30/22  American Equity Inv Life Hold… Co S-3ASR     11/30/22    5:234K
 8/25/22  American Equity Inv Life Hold… Co S-3ASR      8/25/22    8:1.7M
Top
Filing Submission 0001039828-22-000042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 1:17:00.1pm ET